| J9271 | Injection, pembrolizumab, 1 mg | 13,400 | $40 | $562.9K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,430 | $40 | $126.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 250 | $100 | $25.6K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 940 | $20 | $22.6K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 910 | $20 | $21.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 120 | $140 | $16.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $140 | $10.3K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 30 | $210 | $6.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 60 | $100 | $6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $160 | $6K |